Despite recently updated guidelines, urate-lowering therapy use, and the achievement of urate targets, remain low for patients with gout in the United Kingdom, according to data published in Lancet Europe.
“Gout is unique among the inflammatory arthritides in that it has curative, long-term treatments in the form of urate-lowering medications, such as allopurinol,” Mark D. Russell, MD, of the Centre for Rheumatic Diseases at King’s College in London, told Healio. “However, previous studies had shown that these medications are not used as frequently as they should be or at